A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
BioNTech SE
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Bristol-Myers Squibb
Pheon Therapeutics
AstraZeneca
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
AstraZeneca
Exelixis
Astellas Pharma Inc
Astellas Pharma Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis
Kura Oncology, Inc.
Zymeworks BC Inc.
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
AbbVie
Travera Inc
Eli Lilly and Company
Iambic Therapeutics, Inc
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Plexium, Inc.
OncoC4, Inc.
Jazz Pharmaceuticals
Genmab
Revolution Medicines, Inc.
Novartis
Exscientia AI Limited
Seagen Inc.
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Pfizer
Pfizer
Fate Therapeutics
Regeneron Pharmaceuticals
Cancer Research UK
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.